Skip to main content
logo
Prescient Therapeutics Limited (ASX:PTX)
Australia flag Australia · Delayed Price · Currency is AUD
0.0670
+0.0020 (3.08%)
Sep 11, 2026, 11:34 AM AEST

Prescient Therapeutics Financials Overview

Millions AUD. Fiscal year is Jul - Jun.

Revenue & Profits
Chart
Fiscal YearTTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingJun '26 Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Revenue
3.453.454.363.712.431.89
Revenue Growth
-19.10%-20.78%17.35%52.89%28.52%59.37%
Gross Profit
3.453.454.363.712.431.89
Operating Income
-7.14-7.14-7.54-7.19-7.46-5.21
Net Income
-7-7-7.32-8.24-7-5.12
Earnings Per Share
-0.01-0.01-0.01-0.01-0.01-0.01
EPS Growth
------

Cash & Debt
Chart
Fiscal YearCurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingJun '26 Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Cash & Investments
9.059.056.9314.5121.9212.28
Total Debt
0.220.22-0.33--
Net Cash (Debt)
8.838.836.9314.1821.9212.28
Net Cash Growth
-7.06%27.41%-51.16%-35.28%78.41%-22.99%
Net Cash Per Share
0.010.010.010.020.030.02

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingJun '26 Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Operating Cash Flow
-7.22-7.22-7.24-7.4-6.19-4.31
Capital Expenditures
------0
Free Cash Flow
-7.22-7.22-7.24-7.4-6.19-4.32
Free Cash Flow Growth
------

Margins
Chart
Fiscal YearTTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingJun '26 Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Gross Margin
100.00%100.00%100.00%100.00%100.00%100.00%
Operating Margin
-206.89%-206.89%-172.98%-193.58%-307.14%-275.75%
Pretax Margin
-202.91%-202.91%-168.09%-221.91%-288.47%-270.85%
Profit Margin
-202.91%-202.91%-168.09%-221.91%-288.47%-270.85%
FCF Margin
-209.33%-209.33%-166.27%-199.28%-254.97%-228.50%

Valuation
Chart
Fiscal YearCurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingSep '26 Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Forward PE
-5.245.245.245.245.24
PS Ratio
19.8018.598.138.2426.8653.68